Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Vioxx fears prompt call for user fee evaluation

Nature Reviews Drug Discovery volume 4, page 179 (2005)Cite this article

The FDA is compromised by its funding source, but not in the way the public thinks, say experts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Simon Frantz
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frantz, S. Vioxx fears prompt call for user fee evaluation. Nat Rev Drug Discov 4, 179 (2005). https://doi.org/10.1038/nrd1689

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nrd1689

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing